Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-000800

Treasurer and CFO acquired 2,812 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MELLETT PAUL J · Treasurer and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-09 Exercise or conversion : show line 1 in the form +2,812 $14.18 $39,874 88,463 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-09 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −2,812 0 D
Loading xslF345X03/form4.xml…